Detail

Study ID: COG AAML1531

Title:

Risk-stratified Therapy for Acute Myeloid Leukemia in Down Syndrome A COG Groupwide Phase III Study

Location:
Principal Investigator:
Disease:
AML (Acute Myelogenic Leukemia)
Stage:
Phase III
Status:
Active - Open to Accrual